中文名:OSI-906(Linsitinib),双重IGF-1R和胰岛素受体激酶抑制剂
英文名:OSI-906 (Linsitinib)
中文别名:顺式-3-[8-氨基-1-(2-苯基-7-喹啉基)咪唑并[1,5-A]吡嗪-3-基]-1-甲基环丁醇
英文别名:Linsitinib|867160-71-2|OSI-906|Linsitinib(OSI-906)|OSI906|OSI 906|OSI-906AA|OSI-906 (Linsitinib)|ASP-7487|3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol|15A52GPT8T|CHEMBL1091644|MMV676605|cis-3-(8-amino-1-(2-phenyl
纯度:≥99%
货号:L126224
包装:10mg、50mg、5mg
Cas号:867160-71-2
存储温度:-20°C储存
产品介绍:
Linsitinib is a potent, selective insulin-like growth factor-1 receptor (IGF-1R, IC50 = 35 nM) and insulin receptor (IR, IC50 = 75 nM) kinase inhibitor which works to block the autophosphorylation of IGF-1R and IR. Additionally, in vitro studies of Linsitinib have demonstrated its ability to inhibit the proliferation of multiple tumor cell lines.Linsitinib is a selective inhibitor of IGF-1R with IC50 of 35 nM, and modestly potent to InsR with IC50 of 75 nM, and has no activity towards Abl, ALK, BTK, EGFR, FGFR1/2, PKA etc.
查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/L126224.html
关键字: 顺式-3-[8-氨基-1-(2-苯基-7-喹啉基)咪唑并[1,5-A]吡嗪-3-基]-1-甲基环丁醇;Linsitinib;867160-71-2;OSI-906
上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。
阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内(www.aladdin-e.com)和海外(www.aladdinsci.com)电商平台。